These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 5529995
41. [Recurrence prevention of papillomas of the bladder using lycurim instillation]. Zárandy B, Szabó J, Molnár I, Sallai Z, Simon Z, Légrády J. Z Urol Nephrol; 1984 Oct; 77(10):599-603. PubMed ID: 6549094 [Abstract] [Full Text] [Related]
42. [Whole bladder wall laser irradiation to prevent bladder cancer recurrence with intravesical HpD and ascorbic acid]. Li C, Chen Y, Wang Q. Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):463-5. PubMed ID: 10920885 [Abstract] [Full Text] [Related]
44. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder]. Toulouse J, Bouffier B, Etievent JP, Bittard M. J Urol (Paris); 1983 Dec; 89(2):85-9. PubMed ID: 6408192 [Abstract] [Full Text] [Related]
45. [Intravesical chemical prevention of recurrence of superficial urothelial bladder cancer. Progress report of the Urology Clinic of Mainz University 1975-1981]. Jacobi GH, Engelmann U, Frohneberg D, Thüroff JW. Helv Chir Acta; 1982 Aug; 49(3-4):345-8. PubMed ID: 6813292 [No Abstract] [Full Text] [Related]
46. [The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence]. Korovin AI, Savvin VT. Urol Nefrol (Mosk); 1996 Aug; (1):19-21. PubMed ID: 8659034 [Abstract] [Full Text] [Related]
47. [The prevention of the recurrence of stage pTa bladder tumors using intravesical instillation of BCG]. Wetzel O, Glemain P, Bouchot O, Guillonneau B, Baron M, Buzelin JM, Auvigne J. Prog Urol; 1993 Aug; 3(4):595-607. PubMed ID: 8401620 [Abstract] [Full Text] [Related]
48. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study. Hinotsu S, Akaza H, Isaka S, Kanetake H, Kubota Y, Kuroda M, Shinohara N, Shinka T, Tachibana M, Naito S, Hirao Y, BCG Tokyo 172 Strain Study Group. Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576 [Abstract] [Full Text] [Related]
49. [Intravesical therapy: Influence on superficial bladder cancer recurrence]. García Rodríguez J, Fernández Gómez JM, Escaf Barmadah S, González Alvarez RC, Jalón Monzón A, Martínez Gómez FJ, Sánchez Trilla A, Regadera Sejas J. Arch Esp Urol; 2007 Mar; 60(1):36-43. PubMed ID: 17408170 [Abstract] [Full Text] [Related]
50. [Photodynamic therapy of superficial cancer of the urinary bladder to prevent relapse]. Rusakov IG, Sokolov VV, Bystrov AA. Vopr Onkol; 2006 Mar; 52(6):675-9. PubMed ID: 17338248 [No Abstract] [Full Text] [Related]
51. [Intravesical instillation of cytotoxic T-lymphocytes induced by soluble tumor antigen in the prophylaxis of recurrence of bladder cancer]. Li X, Sun D, Gao W. Zhonghua Wai Ke Za Zhi; 2001 Aug; 39(8):619-22. PubMed ID: 11758203 [Abstract] [Full Text] [Related]
52. [Prevention of local recurrences in recurring, non-invasively growing bladder cancer. Preliminary report]. Lutherer S, Cranidis A, Terhorst B. Helv Chir Acta; 1982 Aug; 49(3-4):357-9. PubMed ID: 7129900 [No Abstract] [Full Text] [Related]
53. [The holmium laser in the treatment of bladder cancer patients]. Mazo EB, Chepurov AK. Urol Nefrol (Mosk); 1996 Aug; (4):34-5. PubMed ID: 8928348 [Abstract] [Full Text] [Related]
54. [Postoperative prophylactic intravesical instillation of tetrahydropyranyl-adriamycin (THP) for superficial bladder cancer]. Kanayama H, Yokota K, Kurokawa Y, Kagawa S, Yokozeki H, Inai T, Ogawa I, Akazawa S, Hashimoto H, Mizuta K. Gan To Kagaku Ryoho; 1999 Apr; 26(5):651-5. PubMed ID: 10234296 [Abstract] [Full Text] [Related]
55. [Intravesial instillation of recombination interferon-alpha and pirarubicin in the prophylaxis of local recurrence after resection of the superficial bladder cancer]. Deng JH, Bai JL, Zhang SS, Ma PC, Wan JH. Ai Zheng; 2004 Jul; 23(7):839-41. PubMed ID: 15248924 [Abstract] [Full Text] [Related]
56. [Short-term intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor]. Kuroda K, Ishii N, Fukasawa K, Shirai M, Tajima M, Matsushima M, Miura K, Takanami M, Matsuhashi M, Kuwabara T, Matsumoto H, Sugita M. Hinyokika Kiyo; 1998 Aug; 44(8):547-52. PubMed ID: 9783189 [Abstract] [Full Text] [Related]
57. Clinicopathological evaluation of repeated courses of intravesical bacillus Calmette-Guerin instillation for preventing recurrence of initially resistant superficial bladder cancer. Okamura T, Tozawa K, Yamada Y, Sakagami H, Ueda K, Kohri K. J Urol; 1996 Sep; 156(3):967-71. PubMed ID: 8709375 [Abstract] [Full Text] [Related]
58. [Evaluation of the efficacy of oral methotrexate in the prophylaxis of recurrences of superficial tumors of the bladder]. Nogueira March JL, Ojea A, Figueiredo L, Jamardo D, Diez E, Pérez-Villanueva J. Actas Urol Esp; 1984 Sep; 8(5):391-4. PubMed ID: 6524485 [No Abstract] [Full Text] [Related]
59. Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer. Messing E, Kim KM, Sharkey F, Schultz M, Parnes H, Kim D, Saltzstein D, Wilding G. J Urol; 2006 Aug; 176(2):500-4. PubMed ID: 16813878 [Abstract] [Full Text] [Related]
60. [Mechanism of preventing the recurrence of bladder carcinoma by intravesical instillation of BCG plus IL-2]. Wen R, Zhou G, Xie S, Lian B, Sun X, Chen J. Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):247-8. PubMed ID: 11825381 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]